Two (2) samples of 2 different patients were investigated.Investigation of sample 1 confirmed an interferent against a component of the reagent which is consistent with falsely increased values of the anti-tpo assay.This interference is covered in product labeling: in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.During investigation of sample 2 no interferring factors were found.
|